Rocket Pharmaceuticals (RCKT) Goodwill (2018 - 2026)

Rocket Pharmaceuticals has disclosed Goodwill across 9 years of filings, most recently posting $39.2 million for Q1 2026.

• Goodwill for Q1 2026 came in at $39.2 million, changed 0.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.2 million (changed 0.12% YoY), and the FY2025 annual result was $39.2 million, changed 0.12% from the prior year.
• Goodwill came in at $39.2 million for Q1 2026 at Rocket Pharmaceuticals, roughly flat from $39.2 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $39.2 million in Q4 2022 to a low of $30.8 million in Q1 2022.
• The 5-year median for Goodwill is $39.2 million (2023), against an average of $37.7 million.
• Across the five-year window, Goodwill advanced 27.21% in 2022 and declined 0.12% in 2024, its largest moves.
• Rocket Pharmaceuticals' Goodwill stood at $39.2 million in 2022, then changed by 0.0% to $39.2 million in 2023, then changed by 0.0% to $39.2 million in 2024, then dropped by 0.12% to $39.2 million in 2025, then changed by 0.0% to $39.2 million in 2026.
• The last three Goodwill figures came in at $39.2 million (Q1 2026), $39.2 million (Q4 2025), and $39.2 million (Q3 2025), per Business Quant data.